当前位置：首页 SCI 期刊医学 Coronary Artery Disease(非官网)

Coronary Artery DiseaseSCIE

国际简称：CORONARY ARTERY DIS 参考译名：冠状动脉疾病

中科院分区
4区
CiteScore分区
Q3
JCR分区
Q3

基本信息：: ISSN：0954-6928; E-ISSN：1473-5830; 是否OA：未开放; 是否预警：否; TOP期刊：否

出版信息：: 出版地区：UNITED STATES; 出版商：Lippincott Williams and Wilkins Ltd.; 出版语言：English; 出版周期：Bimonthly; 出版年份：1990; 研究方向：医学-外周血管病

评价信息：: 影响因子：1.5; H-index：58; CiteScore指数：2.5; SJR指数：0.384; SNIP指数：0.472

发文数据：: Gold OA文章占比：10.47%; 研究类文章占比：88.73%; 年发文量：71; 自引率：0; 开源占比：0.0657; 出版撤稿占比：0; 出版国人文章占比：0; OA被引用占比：0.0294...

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Coronary Artery Disease期刊介绍

Coronary Artery Disease welcomes reports of original research with a clinical emphasis, including observational studies, clinical trials, translational research, novel imaging, pharmacology and interventional approaches as well as advances in laboratory research that contribute to the understanding of coronary artery disease. Each issue of Coronary Artery Disease is divided into four areas of focus: Original Research articles, Review in Depth articles by leading experts in the field, Editorials and Images in Coronary Artery Disease. The Editorials will comment on selected original research published in each issue of Coronary Artery Disease, as well as highlight controversies in coronary artery disease understanding and management.

Submitted artcles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.

期刊简介Coronary Artery Disease期刊介绍

《Coronary Artery Disease》自1990出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间：较慢,6-12周
医学
CARDIAC & CARDIOVASCULAR SYSTEMS
SCIE
中科院4区
非预警

Cite Score数据（2024年最新版）Coronary Artery Disease Cite Score数据

CiteScore：2.5
SJR：0.384
SNIP：0.472

学科类别	分区	排名	百分位
大类：Medicine 小类：Cardiology and Cardiovascular Medicine	Q3	225 / 387	41%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Coronary Artery Disease 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：否

大类学科	分区	小类学科	分区
医学	4区	CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统	4区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Coronary Artery Disease JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q3	145 / 220	34.3%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q3	137 / 220	37.95%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

本刊中国学者近年发表论文

1、Inflammation in coronary artery disease-clinical implications of novel HDL-cholesterol-related inflammatory parameters as predictors
Author: Guo, Xuantong; Ma, Lihong

Journal: CORONARY ARTERY DISEASE. 2023; Vol. 34, Issue 1, pp. 66-77. DOI: 10.1097/MCA.0000000000001198
2、Obstructive sleep apnea and cardiovascular events in acute coronary syndrome: a meta-analysis
Author: Tong, Jiangtao; Yu, Qian; Li, Yuan; Du, Jianbo; Qiu, Jian

Journal: CORONARY ARTERY DISEASE. 2023; Vol. 34, Issue 3, pp. 177-184. DOI: 10.1097/MCA.0000000000001207
3、Association between monocyte to high-density lipoprotein ratio and coronary heart disease in US adults in the National Health and Nutrition Examination Surveys 2009-2018
Author: Yan, Shaoyi; Sha, Shuo; Wang, Di; Li, Senjie; Jia, Yongping

Journal: CORONARY ARTERY DISEASE. 2023; Vol. 34, Issue 2, pp. 111-118. DOI: 10.1097/MCA.0000000000001208
4、The relationship between hyperhomocysteinemia and total coronary artery occlusion: a cross-sectional study from Southwest China
Author: Xiao, Kaiyong; Chen, Yuxiong; Xiao, Lian; Sun, Hua; He, Zhongwei; Huang, Guan; Chen, Lvhong; Xv, Lei; Peng, Ling; Li, Juan; Xv, Yuling; Wang, Jianping

Journal: CORONARY ARTERY DISEASE. 2023; Vol. 34, Issue 2, pp. 138-145. DOI: 10.1097/MCA.0000000000001217
5、Comparison between radial and femoral access for percutaneous coronary intervention in left main coronary artery disease: a meta-analysis of nonrandomized trials.
Author: Ye Y¹, Zeng Y.

Journal: Coron Artery Dis. 2019 Mar;30(2):79-86. doi: 10.1097/MCA.0000000000000685.
6、Association of lipoprotein(a) and coronary artery disease in 1003 patients with stage 3-5 chronic kidney disease undergoing coronary angiography.
Author: Lin LH¹, Liu H^2,¹, Tu Y², Yang Y², Wang B^2,¹, Wang FM², Wu M², Pan MM^2,¹, Tang RN^2,¹, Ma KL^2,¹, Zhang XL^2,¹, Liu BC^2,¹.

Journal: Coron Artery Dis. 2019 Mar;30(2):137-142. doi: 10.1097/MCA.0000000000000692.
7、Serum apelin predicts spontaneous reperfusion of infarct-related artery in patients with ST-segment elevation myocardial infarction.
Author: Ying Z¹, Jiansong Y², Yong W¹, Shubin Q².

Journal: Coron Artery Dis. 2019 Mar;30(2):103-108. doi: 10.1097/MCA.0000000000000702.
8、Beneficial effect of ticagrelor on microvascular perfusion in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
Author: Wang X¹, Li X, Wu H, Li R, Liu H, Wang L, Bai S, Zhang L, Chen T, Liu J, Li Q, Du R.

Journal: Coron Artery Dis. 2019 Jan 5. doi: 10.1097/MCA.0000000000000707. [Epub ahead of print]